Tag: Matinas BioPharma

$Good news for Matinas BioPharma’s treatment for Chronic Refractory Mucocutaneous Candidiasis$

January 8, 2018 Off

Good news for Matinas BioPharma’s treatment for Chronic Refractory Mucocutaneous Candidiasis

Matinas BioPharma Holdings said Monday that the National Institutes of Health (NIH) has revealed positive data from a third patient…

February 27, 2017 Off

Matinas BioPharma joins NYSE

By Dino Mustafić

Matinas BioPharma Holdings has been approved for listing on the New York stock exchange, and will be trading under the symbol “MTNB” starting from March 2, 2017.